文献速递真菌感染

耳念珠菌和近平滑念珠菌菌株的(1,3)-β-D-葡聚糖敏感性较低及其体外水平

Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains.
PubMed 文献 · Clin Microbiol Infect · 2024-02-29

本研究纳入22株耳念珠菌、14株白色念珠菌和10株近平滑念珠菌临床分离株,检测上清液BDG水平及同期血清BDG(Fungitell法)敏感性。耳念珠菌和近平滑念珠菌上清液及血清BDG水平均低于白色念珠菌,血清BDG敏感性分别为39%、30%和78%。

要点

  • 耳念珠菌上清液BDG中位数463 pg/mL(IQR 379-648),低于白色念珠菌1080 pg/mL(IQR 830-1276)。
  • 耳念珠菌血清BDG敏感性39%(95%CI 18-64),近平滑念珠菌30%(95%CI 8-65),白色念珠菌78%(95%CI 49-94)。
  • 本中心耳念珠菌和近平滑念珠菌BDG含量低于白色念珠菌,可能影响血清BDG诊断念珠菌血症的性能。

核心结论

  • 本中心耳念珠菌和近平滑念珠菌菌株BDG含量低于白色念珠菌,可能影响血清BDG诊断念珠菌血症的性能。

研究设计与样本

  • 收集血培养为白色念珠菌、近平滑念珠菌和耳念珠菌的患者菌株,患者均在-1至+3天内行血清BDG检测(Fungitell法)。
  • 所有菌株上清液行四倍复孔BDG检测,共纳入22株耳念珠菌、14株白色念珠菌和10株近平滑念珠菌。

主要发现

  • 上清液BDG中位数:耳念珠菌463 pg/mL(IQR 379-648),白色念珠菌1080 pg/mL(IQR 830-1276),近平滑念珠菌755 pg/mL(IQR 511-930),种间差异显著(p < 0.0001)。
  • 血清BDG中位数:耳念珠菌50 pg/mL(IQR 15-161)和近平滑念珠菌57 pg/mL(IQR 18-332)均显著低于白色念珠菌372 pg/mL(IQR 102-520)(p < 0.0001)。
  • 血清BDG敏感性:耳念珠菌39%(95%CI 18-64),近平滑念珠菌30%(95%CI 8-65),白色念珠菌78%(95%CI 49-94)。

关键数值与推荐

  • 上清液BDG中位数耳念珠菌463 pg/mL(IQR 379-648)、白色念珠菌1080 pg/mL(IQR 830-1276)、近平滑念珠菌755 pg/mL(IQR 511-930),种间p < 0.0001。
  • 血清BDG中位数耳念珠菌50 pg/mL(IQR 15-161)、近平滑念珠菌57 pg/mL(IQR 18-332) vs 白色念珠菌372 pg/mL(IQR 102-520),p < 0.0001。
  • 血清BDG敏感性耳念珠菌39%(95%CI 18-64)、近平滑念珠菌30%(95%CI 8-65)、白色念珠菌78%(95%CI 49-94)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The serum (1,3)-beta-d-glucan (BDG) assay gives quicker results and has higher sensitivity than blood cultures, therefore it is advised for early diagnosis of invasive candidemia and/or discontinuation of empirical therapy. Its sensitivity may depend on different factors. The aim of our study was to analyse the in vitro and in vivo BDG levels in clinical isolates of three species of Candida responsible for candidemia. METHODS: C. albicans, C. parapsilosis, and C. auris strains were collected from blood cultures of patients who had a concurrent (-1 to +3 days) serum BDG test (Fungitell assay). Supernatants of all strains were tested in quadruplicate for BDG levels. RESULTS: Twenty-two C. auris, 14 C. albicans, and ten C. parapsilosis strains were included. The median BDG levels in supernatants were 463 pg/mL (interquartile range [IQR] 379-648) for C. auris, 1080 pg/mL (IQR 830-1276) for C. albicans, and 755 pg/mL (IQR 511-930) for C. parapsilosis, with the significant difference among the species (p < 0.0001). Median serum BDG levels (IQR) were significantly lower in case C. auris and C. parapsilosis vs. C. albicans (p < 0.0001), respectively, 50 pg/mL (IQR 15-161) and 57 pg/mL (IQR 18-332), vs. 372 pg/mL (IQR 102-520). Sensitivity of serum BDG was 39% (95% confidence interval [CI], 18-64) in case of C. auris, 30% (95% CI, 8-65) C. parapsilosis and 78% (95% CI, 49-94) C. albicans candidemia. DISCUSSION: In our centre C. auris and C. parapsilosis strains have lower BDG content as compared with C. albicans, with a potential impact on serum BDG performance for the diagnosis of candidemia.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Mikulska M, Ullah N, Magnasco L, et al. Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains. Clin Microbiol Infect. 2024. PMID: 38431255. doi:10.1016/j.cmi.2024.02.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。